The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Diabetes and pancreatic cancer
Open accessAbstract
Type 2 diabetes mellitus is likely the third modifiable risk factor for pancreatic cancer after cigarette smoking and obesity. Epidemiological investigations have found that long‐term type 2 diabetes mellitus is associated with a 1.5‐fold to 2.0‐fold increase in the risk of pancreatic cancer. A causal relationship between diabetes and pancreatic cancer is also supported by findings from prediagnostic evaluations of glucose and insulin levels in prospective studies. Insulin resistance and associated hyperglycemia, hyperinsulinemia, and inflammation have been suggested to be the underlying mechanisms contributing to development of diabetes‐associated pancreatic cancer. Signaling pathways that regulate the metabolic process also play important roles in cell proliferation and tumor growth. Use of the antidiabetic drug metformin has been associated with reduced risk of pancreatic cancer in diabetics and recognized as an antitumor agent with the potential to prevent and treat this cancer. On the other hand, new‐onset diabetes may indicate subclinical pancreatic cancer, and patients with new‐onset diabetes may constitute a population in whom pancreatic cancer can be detected early. Biomarkers that help define high‐risk individuals for clinical screening for pancreatic cancer are urgently needed. Why pancreatic cancer causes diabetes and how diabetes affects the clinical outcome of pancreatic cancer have yet to be fully determined. Improved understanding of the pathological mechanisms shared by diabetes and pancreatic cancer would be the key to the development of novel preventive and therapeutic strategies for this cancer. © 2011 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard, J., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., Capeau, J., & Fève, B. (2006) · PubMed · Cited by 2,095
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559
Very high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,445
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Diabetes and Cancer: A Consensus Report
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,055
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Barone, B. B. (2008) · JAMA · doi:10.1001/jama.2008.824 · Cited by 881
Liang, J., Shao, S. H., Xu, Z.-X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1537 · Cited by 866
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
Everhart, J. (1995) · JAMA · doi:10.1001/jama.273.20.1605 · Cited by 742
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
Wideroff, L., Gridley, G., Chow, W. H., Linet, M., Mellemkjaer, L., Olsen, J. H., Keehn, S., & Borch-Johnsen, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1360 · Cited by 627
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.039 · Cited by 621
Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603
Petersen, G. M., Amundadottir, L., Fuchs, C. S., Kraft, P., Stolzenberg-Solomon, R. Z., Jacobs, K. B., Arslan, A. A., Bueno-de-Mesquita, H. B., Gallinger, S., Gross, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.522 · Cited by 596
Self-citationAntidiabetic Therapies Affect Risk of Pancreatic Cancer
Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.013 · Cited by 584
Self-citationAlimova, I. N., Liu, B., Fan, Z., Edgerton, S. M., Dillon, T., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7933 · Cited by 523
Chari, S. T., Leibson, C. L., Rabe, K. G., Timmons, L. J., Ransom, J., de Andrade, M., & Petersen, G. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.040 · Cited by 517
Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus
Mather, K. J., Verma, S., & Anderson, T. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01129-9 · Cited by 513
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
Landman, G. W. D., Kleefstra, N., van Hateren, K. J. J., Groenier, K. H., Gans, R. O. B., & Bilo, H. J. G. (2010) · Diabetes Care · doi:10.2337/dc09-1380 · Cited by 502
Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells
Isoda, K., Young, J. L., Zirlik, A., MacFarlane, L. A., Tsuboi, N., Gerdes, N., Schönbeck, U., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201938.78044.75 · Cited by 499
Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer
Li, D. (2009) · JAMA · doi:10.1001/jama.2009.886 · Cited by 469
Self-citationCoffee and Cancer of the Pancreas
MacMahon, B., Yen, S., Trichopoulos, D., Warren, K., & Nardi, G. (1981) · New England Journal of Medicine · doi:10.1056/nejm198103123041102 · Cited by 451
Abnormal Glucose Metabolism and Pancreatic Cancer Mortality
Gapstur, S. M. (2000) · JAMA · doi:10.1001/jama.283.19.2552 · Cited by 420
Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis
Memmott, R. M., Mercado, J. R., Maier, C. R., Kawabata, S., Fox, S. D., & Dennis, P. A. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0055 · Cited by 408
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Kovalenko, I. G., Poroshina, T. E., Semenchenko, A. V., Provinciali, M., et al. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.007 · Cited by 402
Insulin, Glucose, Insulin Resistance, and Pancreatic Cancer in Male Smokers
Stolzenberg-Solomon, R. Z. (2005) · JAMA · doi:10.1001/jama.294.22.2872 · Cited by 400
Silverman, D. T., Schiffman, M., Everhart, J., Goldstein, A., Lillemoe, K. D., Swanson, G. M., Schwartz, A. G., Brown, L. M., Greenberg, R. S., Schoenberg, J. B., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690607 · Cited by 397
KIM, J., LEE, K. T., LEE, J. K., PAIK, S. W., RHEE, J. C., & CHOI, K. W. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03219.x · Cited by 394
Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion
Brissova, M., Shiota, M., Nicholson, W. E., Gannon, M., Knobel, S. M., Piston, D. W., Wright, C. V. E., & Powers, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111272200 · Cited by 375
Impact of Diabetes Mellitus on Outcomes in Patients With Colon Cancer
Meyerhardt, J. A., Catalano, P. J., Haller, D. G., Mayer, R. J., Macdonald, J. S., Benson, A. B., & Fuchs, C. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.125 · Cited by 374
Diabetes and the Risk of Pancreatic Cancer
Gullo, L., Pezzilli, R., & Morselli-Labate, A. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310203 · Cited by 367
Risk Factors for Pancreatic Cancer: Case-Control Study
Hassan, M. M., Bondy, M. L., Wolff, R. A., Abbruzzese, J. L., Vauthey, J.-N., Pisters, P. W., Evans, D. B., Khan, R., Chou, T.-H., Lenzi, R., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01510.x · Cited by 331
Self-citationHyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Pisani, P. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954451 · Cited by 329
Prevention of pancreatic cancer induction in hamsters by metformin
Schneider, M. B., Matsuzaki, H., Haorah, J., Ulrich, A., Standop, J., Ding, X., Adrian, T. E., & Pour, P. M. (2001) · Gastroenterology · doi:10.1053/gast.2001.23258 · Cited by 327
A case-control study of diabetes mellitus and cancer risk
La Vecchia, C., Negri, E., Franceschi, S., D'Avanzo, B., & Boyle, P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.427 · Cited by 320
Cancer risk in patients with diabetes mellitus
Adami, H.-O., McLaughlin, J., Ekbom, A., Berne, C., Silverman, D., Hacker, D., & Persson, I. (1991) · Cancer Causes and Control · doi:10.1007/bf00051670 · Cited by 319
Does diabetes therapy influence the risk of cancer?
Smith, U., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1441-5 · Cited by 316
Kisfalvi, K., Eibl, G., Sinnett-Smith, J., & Rozengurt, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0418 · Cited by 315
Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
Hosono, K., Endo, H., Takahashi, H., Sugiyama, M., Sakai, E., Uchiyama, T., Suzuki, K., Iida, H., Sakamoto, Y., Yoneda, K., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0186 · Cited by 311
Metformin: New Understandings, New Uses
Hundal, R. S., & Inzucchi, S. E. (2003) · Drugs · doi:10.2165/00003495-200363180-00001 · Cited by 308
Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H. G., & Korc, M. (1995) · PubMed · Cited by 304
Tirosh, A., Potashnik, R., Bashan, N., & Rudich, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10595 · Cited by 301
Dietary habits and past medical history as related to fatal pancreas cancer risk among adventists
Mills, P. K., Beeson, W. L., Abbey, D. E., Fraser, G. E., & Phillips, R. L. (1988) · Cancer · doi:10.1002/1097-0142(19880615)61:12<2578::aid-cncr2820611232>3.0.co;2-0 · Cited by 297
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
Richardson, L. C., & Pollack, L. A. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0062 · Cited by 289
Smith, T. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002469 · Cited by 267
Diet and other risk factors for cancer of the pancreas
Gold, E. B., Gordis, L., Diener, M. D., Seltser, R., Boitnott, J. K., Bynum, T. E., & Hutcheon, D. F. (1985) · Cancer · doi:10.1002/1097-0142(19850115)55:2<460::aid-cncr2820550229>3.0.co;2-v · Cited by 247
Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer
Permert, J., Ihse, I., Jorfeldt, L., von Schenck, H., Arnquist, H. J., & Larsson, J. (1993) · Journal of British Surgery · doi:10.1002/bjs.1800800841 · Cited by 244
Islet Amyloid Polypeptide in Patients with Pancreatic Cancer and Diabetes
Permert, J., Larsson, J., Westermark, G. T., Herrington, M. K., Christmanson, L., Pour, P. M., Westermark, P., & Adrian, T. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402033300503 · Cited by 242
Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
Pollak, M. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0175 · Cited by 240
Mohanty, P., Ghanim, H., Hamouda, W., Aljada, A., Garg, R., & Dandona, P. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.767 · Cited by 239
A multifactorial model for pancreatic cancer in man. Epidemiologic evidence
Lin, R. S. (1981) · JAMA · doi:10.1001/jama.245.2.147 · Cited by 236
Ragozzino, M., Melton, L. J., Chu, C.-P., & Palumbo, P. J. (1982) · Journal of Chronic Diseases · doi:10.1016/0021-9681(82)90025-x · Cited by 222
(1993) · PubMed · Cited by 222
DE JAGER, J., KOOY, A., LEHERT, P., BETS, D., WULFFELÉ, M. G., TEERLINK, T., SCHEFFER, P. G., SCHALKWIJK, C. G., DONKER, A. J. M., & STEHOUWER, C. D. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01420.x · Cited by 220
Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1
Powell, D. R., Suwanichkul, A., Cubbage, M. L., DePaolis, L. A., Snuggs, M. B., & Lee, P. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55144-9 · Cited by 217
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case–control studies
Li, D., Tang, H., Hassan, M. M., Holly, E. A., Bracci, P. M., & Silverman, D. T. (2011) · Cancer Causes & Control · doi:10.1007/s10552-010-9686-3 · Cited by 215
Self-citationDiabetes mellitus and cancer risk: A multisite case-control study
O'Mara, B. A., Byers, T., & Schoenfeld, E. (1985) · Journal of Chronic Diseases · doi:10.1016/0021-9681(85)90139-0 · Cited by 215
Cancer Mortality Among Diabetics 2
(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/44.3.673 · Cited by 212
A prospective study of pancreatic cancer in the elderly
Shibata, A., Mack, T. M., Paganini‐Hill, A., Ross, R. K., & Henderson, B. E. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580109 · Cited by 212
Weiser, M. A., Cabanillas, M. E., Konopleva, M., Thomas, D. A., Pierce, S. A., Escalante, C. P., Kantarjian, H. M., & O'Brien, S. M. (2004) · Cancer · doi:10.1002/cncr.20071 · Cited by 204
Pancreatic cancer, alcohol, diabetes mellitus and gall‐bladder disease
Cuzick, J., & Babiker, A. G. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430312 · Cited by 194
Sulphonylureas and cancer: a case-control study
Monami, M., Lamanna, C., Balzi, D., Marchionni, N., & Mannucci, E. (2009) · Acta Diabetologica · doi:10.1007/s00592-008-0083-2 · Cited by 194
Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds
Rulyak, S. J., Lowenfels, A. B., Maisonneuve, P., & Brentnall, T. A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00272-5 · Cited by 191
Risk Factors for Pancreatic Cancer: An Exploratory Study
FRIEDMAN, G. D., & VAN DEN EEDEN, S. K. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.1.30 · Cited by 186
Lago, R., Gómez, R., Lago, F., Gómez-Reino, J., & Gualillo, O. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.004 · Cited by 185
Hosono, K., Endo, H., Takahashi, H., Sugiyama, M., Uchiyama, T., Suzuki, K., Nozaki, Y., Yoneda, K., Fujita, K., Yoneda, M., et al. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20637 · Cited by 177
Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee
Farrow, D. C., & Davis, S. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450504 · Cited by 175
Stoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parikh, A. A., Bucana, C. D., Evans, D. B., Semenza, G. L., & Ellis, L. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63460-8 · Cited by 175
Blendea, M. C., Jacobs, D., Stump, C. S., McFarlane, S. I., Ogrin, C., Bahtyiar, G., Stas, S., Kumar, P., Sha, Q., Ferrario, C. M., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00402.2004 · Cited by 171
Aljada, A., Ghanim, H., Mohanty, P., Syed, T., Bandyopadhyay, A., & Dandona, P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.51 · Cited by 167
Kalapothaki, V., Tzonou, A., Hsieh, C.-C., Toupadaki, N., Karakatsani, A., & Trichopoulos, D. (1993) · Cancer Causes and Control · doi:10.1007/bf00051341 · Cited by 165
Dhindsa, S., Tripathy, D., Mohanty, P., Ghanim, H., Syed, T., Aljada, A., & Dandona, P. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.013 · Cited by 160
Effect of High-Dose Vitamin E on Insulin Resistance and Associated Parameters in Overweight Subjects
Manning, P. J., Sutherland, W. H. F., Walker, R. J., Williams, S. M., de Jong, S. A., Ryalls, A. R., & Berry, E. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2166 · Cited by 159
Inflammation and pancreatic cancer: an evidence-based review
Greer, J. B., & Whitcomb, D. C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.011 · Cited by 157
Ogihara, T., Asano, T., Katagiri, H., Sakoda, H., Anai, M., Shojima, N., Ono, H., Fujishiro, M., Kushiyama, A., Fukushima, Y., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1391-x · Cited by 153
Heuson, J.-C., & Legros, N. (1972) · PubMed · Cited by 151
Radiosurgery of acoustic neurinomas
Flíckinger, J. C., Lunsford, L. D., Coffey, R. J., Linskey, M. E., Bissonette, D. J., Maitz, A. H., & Kondziolka, D. S. (1991) · Cancer · doi:10.1002/1097-0142(19910115)67:2<486::aid-cncr2820670228>3.0.co;2-1 · Cited by 149
Stein, K. B., Snyder, C. F., Barone, B. B., Yeh, H., Peairs, K. S., Derr, R. L., Wolff, A. C., & Brancati, F. L. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0944-8 · Cited by 149
Socio-economic and lifestyle factors associated with the risk of prostate cancer
Nilsen, T. I. L., Johnsen, R., & VATTEN, L. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1105 · Cited by 146
Midaoui, A. E., Elimadi, A., Wu, L., Haddad, P. S., & de Champlain, J. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03253-3 · Cited by 146
LKB1 and AMPK in cell polarity and division
Williams, T., & Brenman, J. E. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.008 · Cited by 142
Wohlfert, E. A., Nichols, F. C., Nevius, E., & Clark, R. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4129 · Cited by 136
Gopaul, N. K., Manraj, M., Hébé, A., YAN, S., Johnston, A. E., CARRIER, M. J., & Änggård, E. (2001) · Diabetologia · doi:10.1007/s001250051679 · Cited by 133
Batty, G. D., Shipley, M. J., Marmot, M. G., & Smith, G. D. (2004) · Cancer Causes & Control · doi:10.1007/s10552-004-1050-z · Cited by 131
Risk of Pancreatic Cancer Following Diabetes Mellitus: a Nationwide Cohort Study in Sweden
Chow, W.-H., Gridley, G., Nyrén, O., Linet, M. S., Ekbom, A., Fraumeni, J. F., & Adami, H. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.12.930 · Cited by 127
The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients
Ersoy, C., Kiyici, S. K., Budak, F., Oral, H. B., Güçlü, M., Duran, C., Selimoğlu, H., Ertürk, E., Tuncel, E., & İmamoğlu, Ş. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.02.006 · Cited by 127
Stolzenberg‐Solomon, R. Z., Pietinen, P., Taylor, P. R., Virtamo, J. R. K., & Albanes, D. (2002) · Cancer Causes & Control · doi:10.1023/a:1015729615148 · Cited by 124
Ding, X., Fehsenfeld, D. M., Murphy, L. O., Permert, J., & Adrian, T. E. (2000) · Pancreas · doi:10.1097/00006676-200010000-00014 · Cited by 115
Inoue, M., Tajima, K., Takezaki, T., Hamajima, N., Hirose, K., Ito, H. M., & Tominaga, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg062 · Cited by 115
Smith, G. D., Egger, M., Shipley, M. J., & Marmot, M. G. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116576 · Cited by 114
Wang, F., Gupta, S. N., & Holly, E. A. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0188 · Cited by 113
Coffee and alcohol as determinants of risk of pancreas cancer: A case‐control study from toronto
Jain, M., Howe, G. R., Louis, P. S., & Miller, A. B. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470313 · Cited by 110
Huang, H., Dong, X., Kang, M. X., Xu, B., Chen, Y., Zhang, B., Chen, J., Xie, Q. P., & Wu, Y. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.32 · Cited by 109
Bonelli, L. A., Aste, H., Bovo, P., Cavallini, G., Felder, M., Gusmaroli, R., Morandini, E., Ravelli, P., Briglia, R., Lombardo, L., et al. (2003) · Pancreas · doi:10.1097/00006676-200308000-00007 · Cited by 107
Lin, Y., Tamakoshi, A., Kawamura, T., Inaba, Y., Kikuchi, S., Motohashi, Y., Kurosawa, M., Ohno, Y., & JACC Study Group (2002) · International Journal of Cancer · doi:10.1002/ijc.10402 · Cited by 105
Bueno-de-Mesquita, H. B., Maisonneuve, P., Moerman, C. J., & Walker, A. M. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520105 · Cited by 104
Obesity adversely affects survival in pancreatic cancer patients
McWilliams, R. R., Matsumoto, M., Burch, P. A., Kim, G. P., Halfdanarson, T. R., de Andrade, M., Reid–Lombardo, K. M., & Bamlet, W. R. (2010) · Cancer · doi:10.1002/cncr.25465 · Cited by 102
Early precursors of pancreatic cancer in college men
Whittemore, A. S., Paffenbarger, R. S., Anderson, K. M., & Halpern, J. (1983) · Journal of Chronic Diseases · doi:10.1016/0021-9681(83)90059-0 · Cited by 98
Short-term consumption of a high-sucrose diet has a pro-oxidant effect in rats
Busserolles, J., Rock, E., Gueux, E., Mazur, A., Grolier, P., & RAYSSIGUIER, Y. (2002) · British Journal Of Nutrition · doi:10.1079/bjnbjn2002524 · Cited by 98
Shih, D. Q., Heimesaat, M. M., Kuwajima, S., Stein, R. W., Wright, C. V. E., & Stoffel, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062605899 · Cited by 97
Pancreatic cancer, blood glucose and beverage consumption
Hiatt, R. A., Klatsky, A. L., & Armstrong, M. A. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410603 · Cited by 94
Annicotte, J., Fayard, E., Swift, G. H., Selander, L., Edlund, H., Tanaka, T., Kodama, T., Schoonjans, K., & Auwerx, J. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.6713-6724.2003 · Cited by 92
Noy, A., & Bilezikian, J. P. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962312 · Cited by 87
Ooi, G. T., Tseng, L. Y., Tran, M. Q., & Rechler, M. M. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.12.1283442 · Cited by 87
Mulholland, H. G., Murray, L., Cardwell, C. R., & Cantwell, M. M. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26823 · Cited by 86
Pancreatic cancer-derived S-100A8 N-terminal peptide: A diabetes cause?
Basso, D., Greco, E., Fogar, P., Pucci, P., Flagiello, A., Baldo, G., Giunco, S., Valerio, A., Navaglia, F., Zambon, C., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.027 · Cited by 85
Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer
Chari, S. T., Klee, G. G., Miller, L. J., Raimondo, M., & DiMagno, E. P. (2001) · Gastroenterology · doi:10.1053/gast.2001.27210 · Cited by 85
Putative Pancreatic Cancer-Associated Diabetogenic Factor: 2030 MW Peptide
Basso, D., Valerio, A., Seraglia, R., Mazza, S., Piva, M. G., Greco, E., Fogar, P., Gallo, N., Pedrazzoli, S., Tiengo, A., et al. (2002) · Pancreas · doi:10.1097/00006676-200201000-00002 · Cited by 77
CA19-9 as a Screening and Diagnostic Tool in Symptomatic Patients
Satake, K., Takeuchi, T., Homma, T., et al. (1994) · Pancreas · doi:10.1097/00006676-199411000-00005 · Cited by 76
Insulin, Insulin Resistance, Obesity, and Cancer
Gallagher, E. J., & LeRoith, D. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0101-y · Cited by 76
Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer
Wolpin, B. M., Michaud, D. S., Giovannucci, E. L., Schernhammer, E. S., Stampfer, M. J., Manson, J. E., Cochrane, B. B., Rohan, T. E., Ma, J., Pollak, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0373 · Cited by 74
Zeng, H., Datta, K., Neid, M., Li, J., Parangi, S., & Mukhopadhyay, D. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00107-4 · Cited by 67
Wolpin, B. M., Michaud, D. S., Giovannucci, E. L., Schernhammer, E. S., Stampfer, M. J., Manson, J. E., Cochrane, B. B., Rohan, T. E., Ma, J., Pollak, M., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603826 · Cited by 64
Prlic, M., & Bevan, M. J. (2009) · Nature · doi:10.1038/460041a · Cited by 64
Wu, C. H., Wu, T. Y., Li, C.-C., Lui, M.-T., Chang, K. W., & Kao, S. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0996-1 · Cited by 63
Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
Wolf, I., Sadetzki, S., Gluck, I., Oberman, B., Ben-David, M. A., Papa, M. Z., Catane, R., & Kaufman, B. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.027 · Cited by 63
Diabetes: Risk Factor for the Development of Pancreatic Cancer or Manifestation of the Disease?
Fisher, W. E. (2001) · World Journal of Surgery · doi:10.1007/s002680020344 · Cited by 63
New Strategies in Pancreatic Cancer: Emerging Epidemiologic and Therapeutic Concepts
Li, D., & Abbruzzese, J. L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1942 · Cited by 62
Self-citationBasso, D., Brigato, L., Veronesi, A., Panozzo, M., Amadori, A., & Plebani, M. (1995) · PubMed · Cited by 59
Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?
Gerstein, H. C. (2010) · JAMA · doi:10.1001/jama.2010.60 · Cited by 58
Pour, P. M., & Kazakoff, K. R. (1996) · PubMed · Cited by 52
Suzuki, H., Li, Y., Dong, X., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0514 · Cited by 46
Insulin-Like Growth Factor (IGF)-1, IGF-Binding Protein-3, and Pancreatic Cancer in Male Smokers
Stolzenberg‐Solomon, R. Z., Limburg, P. J., Pollak, M., Taylor, P. R., Virtamo, J. R. K., & Albanes, D. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.438.13.3 · Cited by 44
Basso, D., Valerio, A., Brigato, L., Panozzo, M. P., Miola, M., Lucca, T., Ujka, F., Zaninotto, M., Avogaro, A., & Plebani, M. (1997) · Pancreas · doi:10.1097/00006676-199708000-00004 · Cited by 39
Diabetes and pancreatic carcinoma.
Balkau, B., Barrett-Connor, E. L., Eschwège, É., Richard, J. L., Claude, J., & Ducimetière, P. (1993) · PubMed · Cited by 36
Pancreatic Cancer and Diabetes: Is there a Relationship? A Case‐controlled Study
Frye, J. N. R., Inder, W. J., Dobbs, B. R., & Frizelle, F. (2000) · Australian and New Zealand Journal of Surgery · doi:10.1046/j.1440-1622.2000.01940.x · Cited by 35
Diabetes, gall stone disease, and pancreatic cancer
Norell, S. E., Ahlbom, A., Erwald, R., Jacobson, G., Lindberg-Navier, I., Olin, R. G., & Wiechel, K.-L. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.185 · Cited by 31
Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster
Ahrén, B., & Andrén-Sandberg, Å. (1993) · Research in Experimental Medicine · doi:10.1007/bf02576207 · Cited by 30
Risk factors for pancreatic cancer in Orientals
Lee, C. T., Chang, F., & LEE, S. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00296.x · Cited by 30
Ganti, A. K., Potti, A., Koch, M., Tendulkar, K. K., Hanekom, D., Koka, V., & Levitt, R. (2002) · Medical Oncology · doi:10.1385/mo:19:4:233 · Cited by 26
Genetic determinants of diabetes are similarly associated with other immune-mediated diseases
Duffy, D. L. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282f1dc99 · Cited by 25
[Diabetes mellitus and pancreatic cancer: a case-control study in greater Montreal, Quebec, Canada].
Ékoé, J.-M., Ghadirian, P., Simard, A., Baillargeon, J., & Perret, C. (1992) · PubMed · Cited by 19
The Specificity of Amylin for the Diagnosis of Pancreatic Adenocarcinoma
Brand, R. E., Ding, X., Young, C. M., & Adrian, T. E. (2002) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:31:1-3:123 · Cited by 11
Saruç, M., Iki, K., & Pour, P. M. (2010) · PubMed · doi:10.14670/hh-25.423 · Cited by 9
Cited by
Obesity and cancer: inflammation bridges the two
Kolb, R., Sutterwala, F. S., & Zhang, W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.005 · Cited by 405
European cancer mortality predictions for the year 2014
Malvezzi, M., Bertuccio, P., Levi, F., La Vecchia, C., & Negri, E. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu138 · Cited by 382
The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks
Aunan, J. R., Cho, W. C., & Søreide, K. (2017) · Aging and disease · doi:10.14336/ad.2017.0103 · Cited by 373
Structural similarities and differences between the human and the mouse pancreas
Dolenšek, J., Rupnik, M. S., & Stožer, A. (2015) · Islets · doi:10.1080/19382014.2015.1024405 · Cited by 348
Bosetti, C., Rosato, V., Li, D., Silverman, D., Petersen, G. M., Bracci, P. M., Neale, R. E., Muscat, J., Anderson, K., Gallinger, S., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu276 · Cited by 283
Self-citation
Metadata
- Authors
- Li, D.
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 2011-12-12
- Volume
- 51
- Issue
- 1
- Pages
- 64-74
- ISSN
- 0899-1987 (ISSN-L)
- 1098-2744
- OpenAlex
- W2136383161
- Cited by
- 315
- References
- 145
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.